Ameriprise’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $847K | Buy |
154,854
+36,892
| +31% | +$202K | ﹤0.01% | 3310 |
|
|
2025
Q1 | $742K | Buy |
117,962
+21,178
| +22% | +$133K | ﹤0.01% | 3308 |
|
|
2024
Q4 | $399K | Buy |
96,784
+63,067
| +187% | +$260K | ﹤0.01% | 3579 |
|
|
2024
Q3 | $113K | Buy |
33,717
+18,769
| +126% | +$62.7K | ﹤0.01% | 3813 |
|
|
2024
Q2 | $44.5K | Sell |
14,948
-6,660
| -31% | -$19.8K | ﹤0.01% | 3821 |
|
|
2024
Q1 | $74.5K | Buy |
+21,608
| New | +$74.5K | ﹤0.01% | 3799 |
|